NWM
AGIO icon

Northcape Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Northcape Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,240
Closed -$210K – 139
2025
Q3 		$210K Buy
+5,240
New +$197K 0.06% 136
2024
Q4 		– Sell
-5,670
Closed -$252K – 142
2024
Q3 		$252K Hold
5,670
– – 0.08% 125
2024
Q2 		$244K Buy
+5,670
New +$205K 0.09% 125
2023
Q4 		– Sell
-10,010
Closed -$248K – 138
2023
Q3 		$248K Hold
10,010
– – 0.09% 128
2023
Q2 		$283K Sell
10,010
-500
-5% -$12.4K 0.1% 131
2023
Q1 		$241K Buy
+10,510
New +$279K 0.09% 134

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Northcape Wealth Management's AGIO Position: Q4 2025 in Review

Northcape Wealth Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 5,240 shares — an estimated $210K sold.

Northcape Wealth Management first reported a position in AGIO in Q1 2023 and held it in 6 quarters. The position peaked at $283K in Q2 2023. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Northcape Wealth Management reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Northcape Wealth Management sold 5,240 Agios Pharmaceuticals shares in Q4 2025, an estimated $210K.
  • Northcape Wealth Management first reported a position in Agios Pharmaceuticals in Q1 2023 and held it in 6 quarters.
  • Northcape Wealth Management's Agios Pharmaceuticals position peaked at $283K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Northcape Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.